Best Life Sciences Platforms and Tools Companies in Houston, United States
The 36 best Life Sciences Platforms and Tools companies in Houston, United States in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: AlloVir.
Our analysis of 50 Life Sciences Platforms and Tools companies
$4.8b in tracked funding; 68% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Life Sciences Platforms and Tools companies in Houston
| # | Company | Disclosed funding | Last round | Employees | Founder | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|
| 1 | AlloVir Developer of T-cell therapies to treat infectious diseases | $151M | 88 mo ago | 97 | David Hallal Co-Founder | — | 8 patents Ex vivo expansion and manufacturing of multivirus-specific T‑cell therapies for transplant immunotherapy | — |
| 2 | Lasergen Analytical and clinical lab technologies providing insights and solutions for great science | $85M | 126 mo ago | 6,001 | — | — | 67 patents Photocleavable reagents for nucleic acid sequencing and antigen immunoassay detection. | — |
| 3 | Ingeneron Developer of cell-separation technology for regenerative medicine | $51M | 31 mo ago | 30 | — | WordPressMySQLPHP+18 | 80 patents Patents concentrated in chemistry & materials | — |
| 4 | Celltex Therapeutics Provides services to store adult stem cells for medical treatments | $34M | 170 mo ago | 34 | Stanley Jones Co-Founder & CMO | WordPressMySQLPHP+32 | — | — |
| 5 | GenetiVision Provider of a research and technologies platform in Drosophila transgenesis | $6M | 48 mo ago | — | Rui Chen Co-Founder | — | — | — |
| 6 | AMBiotech Chemically modified nucleic acids as affinity reagents | $6M | 99 mo ago | 7 | — | — | — | — |
| 7 | Atactic Technologies Developer of microfluidic chip technologies and related instrumentation solutions | $5M | 244 mo ago | 6 | — | — | — | — |
| 8 | Synthecon Designs and manufactures 3D cell culture systems | $3M | 191 mo ago | 20 | Bill Anderson CEO | — | 16 patents Scalable stem cell bioreactors and islet aggregation inhibition for cell therapy manufacturing. | — |
| 9 | BreviTest Developer of point of care diagnostic technology for automation of Enzyme Immunoassay | $3M | 57 mo ago | 12 | — | — | 2 patents Point‑of‑care microfluidic diagnostic devices using discontinuous fluidic systems | — |
| 10 | iBioChips Microfluidic biochips for single-cell analysis, cloning, and high-throughput assays | $2M | 107 mo ago | — | Lidong Qin Founder | — | — | — |
| 11 | Optimvia Developer of enzymes and a cofactor for therapeutic use | $598K | 5 mo ago | — | Keith Kleeman CEO | — | 44 patents Patents concentrated in chemistry & materials | — |
| 12 | LC Sciences Provider of products and services for genomics and proteomics research | $572K | 206 mo ago | 18 | — | Node.jsZohoVue.js+8 | — | — |
| 13 | ECM technologies Designs collagens for biomedical needs | $275K | 125 mo ago | — | Brooke Russell Co-Founder & Vice President | — | — | — |
| 14 | n3D In-vitro cell culture technology using 3D magnetic bioprinting | $250K | 103 mo ago | 4 | — | — | — | — |
| 15 | Volumetric Provide of reagents and 3D bio-printers for biofabrication | $125K | 78 mo ago | 11 | Jordan Miller Co-Founder | — | — | — |
Top 12 Life Sciences Platforms and Tools companies in Houston
#1
Seed · Houston, Texas · founded 2010$598.2Kraised▾
Developer of enzymes and a cofactor for therapeutic use. The company has an ADEPT platform, to synthesize enzymes and cofactors for therapeutic purposes. The breakthrough product of the company is Heparin production from the mucosal lining from slaughtered pig intestines to prevent blood clots.
- Mar 2026Seed$75K
- Aug 2023Seed$523.2K
#2
Series D · Houston, Texas · founded 2005 · 30 employees$51.4Mraised▾
InGeneron has developed cell-based technologies for healthcare, veterinary and life science research. InGeneron’s advanced cell separation technologies enable preparation of adipose-derived regenerative cells, including stem cells, that have the potential to aid physicians and veterinarians in the treatment of a number of diseases, orthopedic injuries and cosmetic procedures
- Feb 2024Series D$1.7M
- Apr 2019Series D$23M
- Mar 2017Series D$20M
- Dec 2016Series A$2.1M
#3
Public · Houston, Texas · founded 2013 · 97 employees$151.3Mraised▾
Developer of T-cell therapies to treat infectious diseases. The company has developed a platform for developing the Viralym-M allogenic lead candidate for the treatment of multiple viral diseases. The company focuses on restoring natural T-cell immunity against virus-associated diseases in immunocompromised patients.
- May 2019Series B$121.3M
- Oct 2018Series A$30M
- Aug 2017Grant (prize money)$9M
- Jun 2017Grant (prize money)$3M
#4
Acquired · Houston, Texas · founded 2002 · 6001 employees$85Mraised▾
Analytical and clinical lab technologies providing insights and solutions for great science. The company delivers a comprehensive suite of instruments, software, and services to empower laboratories across diverse sectors. These include chemical analysis, life sciences, and diagnostics. The company offers analytical instruments, lab supplies, and instrument repair. It also provides software and informatics solutions for genomics and lab management. The company serves industries like biopharma, cancer research, environmental, food and beverage testing, and clinical diagnostics. The company provides training, consulting, and compliance services. The company's solutions support research, development, and quality control. The company offers e-commerce, order tracking, and technical support. The company focuses on innovation and sustainability.
- Mar 2016PE$80M
- Aug 2011Series A$5M
#5
Funding Raised · Houston, Texas · founded 2006$6.3Mraised▾
Provider of a research and technologies platform in Drosophila transgenesis. It offers services, like P-element insertions, site-specific insertion using the PhiC31 system, MiMIC/RMCE events, and CRISPR gene targeting. They also offer protein tags, point mutations, and null alleles as needed. including cloning of gRNAs and donor cassettes for CRISPR injections, recombineering-based modification of BACs, PCR genotyping of transgenic insertions.
- Sep 2022Grant (prize money)$1.8M
- Sep 2014Grant (prize money)$1.8M
- Jul 2012Grant (prize money)$2.5M
- Jun 2012Grant (prize money)$197.7K
#6
Series B · Houston, Texas · founded 2011 · 34 employees$34.1Mraised▾
Celltex Therapeutics provides services for the field of regenerative medicine. The company primarily separates, multiplies, and stores adult adipose (fat tissue)-derived mesenchymal stem cells for autologous use by physicians. Its laboratory supplies physicians with genetically identical and autologous adult stem cells for clinical therapeutic use by using a patented process. The company offers its stem cell banking services for adults, families, and groups, and companies.
- Jul 2012Series B$34.1M
#7
Seed · Houston, Texas · founded 2013 · 12 employees$2.7Mraised▾
BreviTest is a developer of patent-pending technology to automate enzyme immunoassays. It offers an analytic biochemical assay device that is used to detect a wide range of biological macromolecules in liquid samples for clinical and research laboratories worldwide. BreviTest's technology attempts to replicate the entire ELISA wet lab process in a microfluidic environment. Currently, the standard test used in clinical laboratories usually takes several hours and requires expensive equipment and experienced technicians.
- Dec 2021Seed$2.7M
- Sep 2018Grant (prize money)$219.2K
- Mar 2017Grant (prize money)$1.7M
- Apr 2016Grant (prize money)$234.4K
#8
Funding Raised · Houston, Texas · founded 2006 · 7 employees$6Mraised▾
AM Biotech develops and commercializes X-Aptamers - short strands of chemically modified nucleic acids that bind to targets with high affinity and specificity. X-Aptamers are easier and faster to develop than other affinity reagents such as antibodies or conventional aptamers. AM Biotech offers customers with X-Aptamer development for their targets of choice, in addition to other services such as siRNA synthesis, optimization of existing aptamers, etc.
- Jun 2018Grant (prize money)$304.2K
- Sep 2013Grant (prize money)$1.9M
- Mar 2012Grant (prize money)$180.1K
- Jul 2011Grant (prize money)$156.7K
#9
Funding Raised · Houston, Texas · founded 1990 · 20 employees$3.5Mraised▾
Designs and manufactures 3D cell culture systems. Its flagship Rotary Cell Culture System enables the co-culturing of multiple cell types in a 3D spheroid morphology and also allows for precise flow control. In addition, the company also makes stem cell culture and perfusion systems, as well as nanobiomatrix and biostructure scaffolds.
- Sep 2010Grant (prize money)$828.4K
- Apr 2009Grant (prize money)$737.8K
- Jan 2009Grant (prize money)$100K
- Nov 2008Grant (prize money)$100K
#10
Funding Raised · Houston, Texas · founded 2003 · 6 employees$5.1Mraised▾
Developer of microfluidic chip technologies and related instrumentation solutions. It offers microfluidic ParafloTM reaction devices, an advanced digital light synthesizer apparatus, and picoliter scale biochemical processes for large scale genomic and proteomic experiments.
- May 2006Grant (prize money)$2.1M
- Mar 2006Grant (prize money)$3M
#11
Funding Raised · Houston, Texas · founded 2015$1.7Mraised▾
Microfluidic biochips for single-cell analysis, cloning, and high-throughput assays. The company develops microplates integrating ultra-low volume assays and microfluidics engineering for high efficiency and precision. They offer innovative biochip approaches to resolve traditional biotech challenges. Their products support single-cell isolation, PCR, sequencing, imaging, spheroid culture, and lifespan assays. They provide tools for genetic screening, cell line development, drug screening, and cytokine analysis. The technology enables automated, high-resolution analysis of cells, including yeast, with applications in aging research, diagnostics, and personalized medicine. Their microfluidic platforms facilitate high-throughput experimentation, single-cell cloning, and 3D cell culture. They offer solutions for researchers in life science, biotechnology, and biomedical fields, providing tools for advanced cellular analysis and manipulation.
- Sep 2017Grant (prize money)$1.7M
#12
Funding Raised · Houston, Texas · founded 2004 · 18 employees$572.4Kraised▾
Provider of products and services for genomics and proteomics research. Its technologies include VariantPro Targeted Sequencing Technology - a multiplex PCR-based targeted sequencing method and µParaflo Microarray Technology for oligonucleotide and peptide synthesis. Its genomics, transcriptomics, and proteomics products and services are based on high-throughput sequencing technology and its flexible µParaflo custom microarrays including services for nucleic acid/protein profiling and functional analysis, biomarker-discovery, and novel drug screening.
- Jul 2009Grant (prize money)$572.4K
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Life Sciences Platforms and Tools coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Bioinformatics in Houston is moving
A read on the academic research around Bioinformatics in Houston — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 103 papers.
- The University of Texas Health Science Center at Houston63
- University of Houston16
- Houston Methodist16
- Houston Fertility Institute4
- Houston Institute for Clinical Research3
- Gene1→6
- Disease7
- DNA methylation4
- Cell3
- Epigenetics3
- Breast cancer3
- Obesity2
- Biosensor1
- Protein detection1
- Sensitivity (control systems)1
- Continuous monitoring1
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.